PH16416A - 4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds - Google Patents

4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds

Info

Publication number
PH16416A
PH16416A PH23804A PH23804A PH16416A PH 16416 A PH16416 A PH 16416A PH 23804 A PH23804 A PH 23804A PH 23804 A PH23804 A PH 23804A PH 16416 A PH16416 A PH 16416A
Authority
PH
Philippines
Prior art keywords
antisecretory
esters
amino
quinolinecarboxylic acids
ulcer compounds
Prior art date
Application number
PH23804A
Other languages
English (en)
Inventor
Randall Munson Harry Jr
Stancil Alphin Reevis
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of PH16416A publication Critical patent/PH16416A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH23804A 1979-03-26 1980-03-25 4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds PH16416A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (1)

Publication Number Publication Date
PH16416A true PH16416A (en) 1983-09-29

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23804A PH16416A (en) 1979-03-26 1980-03-25 4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds

Country Status (31)

Country Link
US (1) US4343804A (de)
JP (1) JPH02117663A (de)
AR (1) AR230268A1 (de)
AT (1) AT372373B (de)
AU (1) AU528388B2 (de)
BR (1) BR8001779A (de)
CA (1) CA1147338A (de)
CH (1) CH644105A5 (de)
DE (1) DE3011490A1 (de)
DK (1) DK156056C (de)
EG (1) EG15009A (de)
ES (1) ES489887A0 (de)
FI (1) FI77452C (de)
FR (1) FR2452485B1 (de)
GB (1) GB2047244B (de)
GR (1) GR68006B (de)
HK (1) HK67983A (de)
IE (1) IE49577B1 (de)
IL (1) IL59628A (de)
IN (1) IN151446B (de)
IT (1) IT1133079B (de)
MX (1) MX6264E (de)
NL (1) NL8001752A (de)
NO (1) NO153927C (de)
NZ (1) NZ193252A (de)
PH (1) PH16416A (de)
PL (1) PL125030B1 (de)
PT (1) PT71008B (de)
SE (1) SE435837B (de)
SG (1) SG33683G (de)
YU (1) YU41702B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
AU682051B2 (en) * 1993-08-10 1997-09-18 James Black Foundation Limited Gastrin and CCK receptor ligands
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
BRPI9914164B8 (pt) 1998-09-29 2021-05-25 American Cyanamid Co compostos de 3-ciano quinolina
NZ519380A (en) * 1999-12-28 2004-10-29 Eisai Co Ltd Heterocyclic compounds having sulfonamide groups
US6521618B2 (en) * 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
KR101078098B1 (ko) 2003-01-14 2011-10-28 아레나 파마슈티칼스, 인크. 대사 조절제로서의 1,2,3-삼치환된 아릴 및 헤테로아릴유도체, 및 당뇨병 및 고혈당증을 비롯한 이에 관련된장애의 예방 및 치료
SI1606261T1 (sl) 2003-03-10 2010-03-31 Nycomed Gmbh Novi postopek za pripravo roflumilasta
AR045697A1 (es) * 2003-07-14 2005-11-09 Arena Pharm Inc Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
CN108558740B (zh) 2010-01-27 2021-10-19 艾尼纳制药公司 S1p1受体调节剂及其盐的制备方法
SG188548A1 (en) 2010-09-22 2013-04-30 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
HUE060476T2 (hu) 2015-06-22 2023-03-28 Arena Pharm Inc (R)-2-(7-(4-ciklopentil-3-(trifluormetil)benziloxi)-1,2,3,4- tetrahidrociklopenta[B]indol-3-il)ecetsav kristályos L-arginin-sója S1P1 receptorral kapcsolatos rendellenességek esetén való alkalmazásra
DK3538512T3 (da) * 2016-11-11 2021-07-05 Bayer Animal Health Gmbh Nye anthelmintiske quinolin-3-carboxamid-derivater
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
EP3700527A4 (de) * 2017-10-25 2021-03-10 Children's Medical Center Corporation Papd5-inhibitoren und verfahren zur verwendung davon
CA3099610A1 (en) 2018-05-09 2019-11-14 Bayer Animal Health Gmbh New quinoline derivatives
US12156866B2 (en) 2018-06-06 2024-12-03 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
EP3959197A4 (de) 2019-04-24 2022-10-12 Children's Medical Center Corporation Papd5-inhibitoren und verfahren zur verwendung davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (de) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
ATA156480A (de) 1983-02-15
PL222993A1 (de) 1981-01-30
FI77452C (fi) 1989-03-10
SG33683G (en) 1985-03-29
NO153927B (no) 1986-03-10
PT71008B (en) 1981-06-25
PL125030B1 (en) 1983-03-31
CA1147338A (en) 1983-05-31
DK156056C (da) 1989-11-06
IL59628A0 (en) 1980-06-30
IL59628A (en) 1983-06-15
GR68006B (de) 1981-10-26
NO800858L (no) 1980-09-29
CH644105A5 (fr) 1984-07-13
NO153927C (no) 1986-06-18
FR2452485A1 (fr) 1980-10-24
FR2452485B1 (fr) 1986-09-12
YU41702B (en) 1987-12-31
HK67983A (en) 1983-12-23
GB2047244B (en) 1983-02-23
US4343804A (en) 1982-08-10
AU528388B2 (en) 1983-04-28
JPH02117663A (ja) 1990-05-02
DK156056B (da) 1989-06-19
AR230268A1 (es) 1984-03-01
AU5684880A (en) 1980-10-02
GB2047244A (en) 1980-11-26
IT8067465A0 (it) 1980-03-26
YU84480A (en) 1983-10-31
NL8001752A (nl) 1980-09-30
SE435837B (sv) 1984-10-22
DK128380A (da) 1980-09-27
BR8001779A (pt) 1980-11-18
PT71008A (en) 1980-04-01
IT1133079B (it) 1986-07-09
ES8103048A1 (es) 1981-02-16
DE3011490A1 (de) 1981-03-12
NZ193252A (en) 1984-04-27
FI800910A7 (fi) 1980-09-27
AT372373B (de) 1983-09-26
DE3011490C2 (de) 1988-12-22
FI77452B (fi) 1988-11-30
IE800605L (en) 1980-09-26
EG15009A (en) 1985-03-31
IE49577B1 (en) 1985-10-30
ES489887A0 (es) 1981-02-16
IN151446B (de) 1983-04-23
SE8002292L (sv) 1980-09-27
MX6264E (es) 1985-02-19

Similar Documents

Publication Publication Date Title
PH16416A (en) 4-amino-3-quinolinecarboxylic acids and esters-antisecretory,anti-ulcer compounds
GB2042535B (en) 1-acylated-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
GB2064520B (en) A-aryl-1h-1,2,4-triazole-1-ethanols
IL60272A0 (en) 7 and 7-8 substituted 4,5 -epoxymorphinan-6-one compounds
IL59829A0 (en) Substituted 9,10-anthracene-bishydrazones
GB2044770B (en) 24,24 - difluoro- 25 - hydroxycholecalciferol
AU521533B2 (en) 1, 2-benzisoxazolozyacetic acids and related compounds
NZ193666A (en) 3-aryl-2-(2,3-dihydrothiazol-2-ylidene)-3-oxopropionitriles
CS409780A1 (en) Zpusob kontinualniho valcovani i profilu
AU9007482A (en) Quilting
GB2043812B (en) Glanded connection
ZA801526B (en) 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds
PH16875A (en) Pyridylaminotriazole anti-ulcer agents
GB2075982B (en) 1-3-dihydroxy-27-nor-cholesta-5-en and 5,7-dien-25-one
ZA804183B (en) 1,2,4-thiadiazolyloxyphenylureas
IL75705A (en) 1,2,5-thiadiazole-1-oxides
JPS5687533A (en) Pyrethroid
JPS5667113A (en) Superconductor
JPS5611808A (en) Superconductor
GB2043811B (en) Glanded connection
GB2118169B (en) 1,1,1-trichlorotriacontane
JPS55145647A (en) Alphaahalomethylamino acids
JPS55100607A (en) Superconductor
CS582579A1 (en) Konstrukcia spoja vhodneho najma pre spajanie nabytkovych dielcov
GB2055832B (en) 1,3,4-thiadiazol-2-yl-4-hydroxy-1-methyl-2-imidaxolidinones